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ABSTRACT
The mammalian orthologue of the evolutionarily conserved Ecdysoneless (ECD) protein
is required for embryogenesis, cell cycle progression and mitigation of ER stress.
However, the molecular mechanisms of ECD function in mammalian cells remain unclear.
Here, using mass spectrometry analysis of the mammalian ECD interactome, we
identified several components of the mRNA export complexes as binding partners of ECD
and then characterized the functional interaction of ECD with key mRNA export-related
DEAD BOX protein helicase DDX39A and its associated partners. FISH analysis of PolyA-tailed mRNAs revealed that ECD depletion/deletion blocks the mRNA export from the
nucleus to the cytoplasm. We have previously shown that ECD is overexpressed in
ErbB2+ breast cancers. ECD depletion in ErbB2+ breast cancer cells led to a decrease in
ErbB2 mRNA level due to a block in its nuclear export and was associated with impairment
of oncogenic traits.

Given the essential role of ECD in mouse embryogenesis and

ECD overexpression in multiple human cancers, our findings that ECD is required
for efficient mRNA export provides a novel mechanistic insight into physiological and
pathological function of ECD.

vii

TABLE OF CONTENTS

Acknowledgements ...................................................................................................iii-v
Abstract.......................................................................................................................... v
Table of content ......................................................................................................vi- vii
List of Figures............................................................................................................ viii
List of Abbreviations…………………………………………………………………… -X

Chapter 1: Introduction ……………………………………………………………………..1
Overview of Ecdysoneless………………………………………………………………….6
Oncogenic function of ECD.………………………………………………………………..7
ECD associated proteins...………………………………………………………………….7
ECD and mRNA processing...………………………………………………….…………..10

Objectives of the dissertation……………………………………………………………..12

Chapter 2: Understanding the role of ECD in mRNA export via its interaction with
DDX39A………………………………………………………………………………………13
Introduction…………………………………………………………………………………..16

viii
Results…………………………………………………………………………………………18
Discussion……………………………………………………………………….……………25
Materials and methods………………………………………………………………………31

Chapter 3: Uncovering ECD as a potential RNA binding protein …………….……69
Introduction………..…………………………………………………………………………..70
Materials and methods……………………………………………………………………….71
Results……………………………………………...…………………………………………..72
Discussion……………………………………………………………………………………..74

Chapter 4: Overall conclusions and future directions……………………………84
Summary………………………………………………………………………….………..85
Future directions…………………………………………………………………..……85
Bibliography……………………………………………………………………………..90

ix

List of Figures
Chapter 1:
Figure 1

…………………………………………………...5

Figure 2

…………………………………………………..9

Chapter 2:
Figure 3

…………………………………………………..39

Figure 4

………………………………………………….42

Figure 5

…………………………………………………..46

Figure 6

…………………………………………………..49

Figure 7

…………………………………………………..52

Figure 8

…………………………………………………..54

Figure 9

…………………………………………………..58

Figure 10

…………………………………………………..63

Figure 11

…………………………………………………..65

Chapter 3:
Figure 12

…………………………………………………..75

Figure 13

…………………………………………………..79

Chapter 4:
Figure 14

…………………………………………………..89

x

List of Tables
Chapter 2:
Table 1

…………………………………………………...38

Table 2

……………………………………………………67

Table 3

…………………………………………………….68

Table 4

…………………………………………………….68

xi

Abbreviations

ATP, adenosine triphosphate
BSA, bovine serum albumin fraction V
CK2, Casein kinase 2
CRM1/exportin1, Chromosome Region Maintenance 1
DAPI, 4'-6-Diamidino-2-phenylindole
DBD, DNA binding domain
DTT, dithiothreitol
Ecd, ecdysoneless
E. coli, Eschericia coli
EGF, epidermal growth factor
ErbB2, Epidermal Growth factor receptor
eGFP, enhanced green fluorescent proteins
EMSA, Electrophoretic Mobility Shift Assay
FISH, Fluorescence in situ Hybridization
GCR2, glycolysis regulation2
GFP, green fluorescent proteins
GST, glutathione S-transferase
hEcd, human Ecdysoneless
h

, hour

HCl, hydrochloric acid
HEPES, N-(2-hydroxyethyl)-piperazine-N’-2-ethanesulfonic acid

xii
HPV, human papilloma virus
hSgt1, human suppressor of GCR two 1
KCl, potassium chloride
NES, nuclear export sequences
LMB, leptomycin B
Mdm2, murine double minute-2
MEF, mouse embryonic fibroblast
MgCl2, magnesium chloride
NaCl, sodium chloride
PBS, phosphate buffered saline
PCR, polymerase chain reaction
Rb, retinoblastoma
RPAP3, RNA Polymerase associated protein 3.
SDS-PAGE, sodium dodecylsulfate-polyacrylamide gel electrophoresis
S. cerevisiae, Saccharomyces cerevisiae
S. pombe, Schizos
accharomyces pombe

1

Chapter 1
Introduction
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RNA biogenesis from pre-mRNA to translation: Ribonucleic acid (RNA) is a significant
intermediate step for transferring genetic information in a cell from DNA to proteins. (1).
Henceforth, processing of RNAs is precisely coordinated with the help of multiple
evolutionary conserved

proteins and protein complexes (2). There are several steps

towards processing of RNA, begins at transcription, splicing, polyadenylation, nuclear
mRNA export, mRNA stability and translation (Figure 1) (3). Depending on the kind of
RNA molecule, i.e. if it is a mRNA or mature RNA or transfer RNA (tRNA) or ribosomal
RNA (rRNA), small nuclear RNA (snRNA) or small nucleolar RNA (snoRNAs) the RNAs
are carefully processed and placed in a spatiotemporal manner (4). The major part of the
RNA pool comprised of mature RNA or mRNA, spliced, exported and translated into
proteins with multiple mRNA binding proteins and protein complexes (Figure 1) (2,5,6).
Thus, in past decade extensive studies have emerged deciphering each steps in mRNA
processing.
The first step in mRNA processing involves splicing. Transcription by RNA polymerases
results in forms of pre mature mRNA, which comprises of both coding regions (exons) and
non-coding regions (introns) (7,8). Splicing is permutation and combination of these exons
and introns, carried out by a RNA-protein complex named spliceosome and associated
splicing factors( (Figure 1) (5 &9). After the splicing of pre-mature mRNA to mature mRNA,
these mRNAs are capped and poly adenylated (to prevent from degradation) and is
exported through nuclear pores complex (NPC) into cytoplasm, where these are translated
by the ribozymes and made into final protein product (5,10-15). The export of mRNAs
from nucleus to cytoplasm is coordinated very diligently with the help of multiple proteins
and mRNPs (Figure 1) (16,17). Efficiency or the kinetics of export of mRNA from nucleus
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to cytoplasm particularly depends on the process of making the mature mRNA and as well
as the export machinery that facilitates the export of mRNAs (5,9). There are multiple
export machineries like nuclear pore complex proteins (NPCs), RNA binding/non-RNA
binding adaptor proteins, chaperone and co-chaperones inside the nucleus, which helps
mRNA to transverse from the nuclear envelope to reach the cytoplasmic compartment
(18).
Two major mRNA export complexes regulating the dynamic export of mRNAs from
nucleus to cytoplasm are, NXF1-NXT1 mediated bulk mRNA export pathway and
CRM1/XPO1 mediated specific mRNA export pathway (19). Both of these export
pathways function in the association with multiple adaptor proteins that associates with
RNA to form mature mRNPs that dock mRNAs to the channels for efficient export. TREX
(TRanscription-EXport) (20) complex is one of the key regulators of NXF1-NXT1 (also
known as TAP-P15) mediated mRNA export, which comprises of adaptor protein Aly
(REF), RNA DEAD box helicases DDX39A/B, CIP29 and other THO complex proteins (2124). NXF1-NXT1 dimer facilitates the transfer of mRNA through nucleoporins by direct
interaction with them, however the kinetics of the export deeply depend upon its
association with adaptor proteins. Interaction of Aly with DDX39A/B is required for its
association or recruitment to mRNA and ATPase cycle of DDX39 is crucial for this
interaction (24). Multiple studies have shown that depletion of these adaptor proteins Aly,
DDX39A/B and/or THO complex subunits blocks mRNA transport and cause accumulation
of poly adenylated mRNA in the nucleus (23).
The other major mRNA export pathway is CRM1-mediated specific mRNA transcript
export pathway. CRM1 facilitate export of ribosomal RNAs, viral RNAs, U-snRNA and
many o mRNAs with the help of certain known and unknown adaptor proteins (25,26).
CRM1 functions as a RNA export factor by its interaction with multiple adaptor proteins
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and unlike NXF1 CRM1 lacks a RNA binding motif, hence, its interaction with the RNA
binding adaptor proteins is crucial for CRM1-mediated mRNA export (19,26-28). The
major known adaptors of CRM1 are HUR/ELAV, HIV REV and eIF4E-LRPPRC proteins
(29). CRM1 export pathway also shares certain adaptor proteins like DDX39B, hnRNPA1
and DDX3 with NXF1 export pathway.
In this thesis, we present data on a evolutionary conserved protein Ecdysonesless (ECD)
as a regulator of mRNA export by associating with proteins known to be involved in both
NXF1-TAP as well as CRM1-mediated nuclear export pathway, to regulate mRNA export
from the nucleus to the cytoplasm.
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Figure 1. Pictorial representation of steps in mRNA processing process of
transcription, splicing, polyadenylation, nuclear export, mRNA stability and
translation is shown .( made with Biorenders.com)
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Overview of Ecdysoneless (ECD), its physiological role in cell cycle
regulation and endoplasmic reticulum (ER) stress.
Ecdysoneless was named after drosophila mutants that are deficient in production of
ecdysone; the insect steroid hormone is critical for larval molting and metamorphosis [26].
The corresponding gene was cloned in 2004 [27] and shown to be the orthologue of a
human gene called hSGT1 (for human suppressor of GCR two) which was cloned based
on complementation of growth defect in Saccharomyces cerevisiae with a deletion of
GCR2 (growth control regulatory gene 2), a transcriptional activator of the glycolytic gene
expression in yeast [28]. Importantly, Ecdysoneless has no structural relationship with
yeast GCR2, nor does a mammalian orthologue of GCR2 exist [28]. Furthermore, an
orthologue of Ecdysoneless is not discernible in S. cerevisiae genome, but highly
conserved orthologues are found throughout higher eukaryotic organisms, including the
yeast Schizosaccharomyces pombe. Consistent with its role in ecdysone synthesis,
drosophila Ecd was found to be highly expressed in ecdysone-producing larval ring gland.
However, the larval lethality of ecd-null fly mutants was not rescued by ecd expression
targeted to the ring gland or by ecdysoneless hormone feeding, supporting a cellautonomous function of Ecd [27, 29]. Ecd was shown to be expressed in the ovary, and
was required in follicle cells and the germline for oocyte development. These defects,
induced by the loss of Ecd, provided the first direct evidence for a cell-autonomous
function of this evolutionarily conserved protein [27]. Notably, even after this publication,
it has remained unclear how ECD functions to regulate steroid synthesis in Drosophila but
recent studies suggest that this role may indeed be linked to the novel role we have
established for mammalian ECD (described below) to mitigate endoplasmic reticulum (ER)
stress [30].
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Recent work shows that ecdysis-triggering hormone (ETH) has also been shown
to attenuate heat stress-induced arrest of oogenesis and egg retention [31]
My mentor’s laboratory previously identified ECD, the human homolog of Drosophila
ecdysoneless as a novel high-risk (cancer-associated) human papilloma virus (HPV) type
16 E6-interacting cellular protein using the yeast two-hybrid system [27]. Our initial studies
showed that ECD can interact with and stabilizes p53, enhancing its function such that
ECD overexpression in fibroblasts promoted p53-dependent senescence [27]. While
these overexpression results, confirmed in other cell types including keratinocytes
(Sameer Mirza et al unpublished studies), suggested a potential p53-dependent tumor
suppressor role for ECD, our extensive subsequent work on ECD instead supports an
essential role of ECD in cell cycle progression and as a promoter of oncogenesis
(described below). Another study confirmed ECD-p53 association, which also interacts
with TXNIP (39) resulting in stabilization of p53.
By engineering a floxed-Ecd mouse model, we showed that germline Ecd
Knockout (KO) is early embryonic lethal; in vitro ECD KO or knockdown (KD) in cells
induced a block in cell cycle progression [28], the effect rescued by exogenous human
ECD. While the N-terminal region of ECD interacts with p53 [27], the C-terminal region
directly interacts with active, hypo-phosphorylated RB (as well as RB-related p107 and
p130), disrupts the RB-E2F association and promotes cell cycle progression [28].
Our laboratory and that of others’ showed that ECD is phosphorylated by casein
kinase 2 (CK2) and its phosphorylation is important for its function [12]; we also showed
that ECD interacts with PIH1D1 [8, 16] and RUVBL1 components [8] of the R2TP
complex (RUVBL1, RUVBL2, RPAP2 and PIH1D1) [16], and these interactions are
required for its cell cycle regulatory function [8].
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Further analysis from our laboratory demonstrated that ECD provides a buffer against
negative consequences of ER stress (e.g., apoptosis) by attenuating PERK signaling, and
this effect was mediated through upregulation of GRP78 protein levels to enhance the
adaptive protein folding in the ER [30].

Oncogenic function of ECD.
A role for ECD in oncogenesis was initially suggested by our observation that
ECD is overexpressed in breast cancers, correlating with increased Ki67 staining and
mitotic index, poor Nottingham prognostic scores and shorter disease-free and overall
survival [9]. We also showed that ECD overexpression correlates with pancreatic tumor
progression and poor prognosis [10]. Other laboratory demonstrated the role of ECD in
gastric tumor progression [

]. Experimentally, we showed that ECD co-overexpression

with mutant Ras rendered non-tumorigenic immortal hMECs full tumorigenic [11].
Recently our laboratory (I am part of this study, Mohapatra et al., manuscript submitted)
analyzed publically available TCGA and METABRIC breast cancer (BC) mRNA datasets
revealed that ECD mRNA is overexpressed in BC and serves as an independent
prognostic marker. In the TCGA dataset, ECD mRNA overexpression correlated with
shorter patient survival in estrogen receptor/progesterone receptor-positive (ER+/PR+)
and HER2+BC. In the METABRIC dataset, ECD mRNA overexpression correlated with
shorter patient survival particularly in triple-negative breast cancer (TNBC), as well as
ErbB2+ BC subtypes. Significantly, multivariate cox regression analysis showed that ECD
mRNA overexpression is an independent poor prognostic marker in BC in both datasets.
Next, we generated mammary epithelium-targeted expression of an inducible (Tet-off)
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human ECD transgene (ECDTg) mouse. Significantly, ECDTg mice exhibit mammary
hyperplasia (85%) in 5-6 months, pre-neoplastic lesions (85%) and heterogeneous tumors
(33%) within 18-24 months. Tumors were both ER- (59%) as well as ER+ (41%).
Transcriptomics analysis of mouse tumors revealed that ECD overexpression upregulates
WNT and c-MYC signaling. Taken together, our studies establish that ECD mRNA
overexpression in BC is an independent prognostic marker, and predicts shorter patient
survival and that ECD overexpression in the mouse mammary gland leads to
tumorigenesis through upregulation of c-MYC and WNT signaling pathways.
All studies listed above provided significance of studying role of ECD in
physiology and pathology. This provided rationale to understand the mechanism by
which ECD functions in the regulation of cell cycle, ER stress and oncogenesis.

ECD and its associated proteins.
As discussed above ECD interacts with a number of proteins including p53, RB, PIH1D1,
DDX39A, TXNIP and GRP78. Furthermore, we and others have shown interaction of ECD
with PRPF8 a core spliceosome protein (46-49). This was first characterized in Drosophila
where the authors have shown ECD interaction with PRP8 (PRPF8 in human) is required
for splicing of spok mRNA and human ECD is can complement this function in the absence
of dECD(48). This interaction is also well characterized in our lab and we reported that in
our mass spectrometry analysis (discussed in detail in chapter 2) we found ECD
interacting with PRPF8 (49). Another interesting association came out in the same mass
spec analysis was RUVBL1 (49). An in vitro study have identified that ECD harbors
DSDDD motif, which is phosphorylated by CK2 and, recognized by P1H1D1, for recruiting
it as its client proteins(50). Both RUVBL1 and P1H1D1 is part of R2TP complex, which
comprises RUVBL1. RUVBL2, PIH1D1 and RPAP3 (46,49). Our lab characterized that
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there is PIH1D1 independent interaction of ECD with RUVBL1 and this interaction is
necessary for its cell cycle regulatory function. Studies that are more recent have shown
that ECD, PRPF8 and RUVBL1 are part of same complex and RUVBL1 interaction with
PRPF8 is required for translocation of PRPF8 from cytoplasm to nucleus (46). Similarly,
ECD is shown to interact with another mRNA binding protein, hnRNPF and prevent its
degradation by E3 ligase ZFP91.(41) Figure 2, shows a schematic of ECD and its
associated partners. Dotted arrows indicate the cellular processing they are known
regulate together. NES, predicted nuclear export signal and A.D, stands for acidic amino
acid rich region, which is required to be involved in transactivation function of ECD.(38,51)

11

Figure 2. Schematic representation of ECD with associated proteins. ( made
with Biorenders.com)
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ECD and mRNA processing.
To mechanistically address the role of ECD further, a former PhD student Dr. Jun Hyun
Kim in my mentor’s laboratory performed a tandem affinity purification of ECD (discussed
below chapter 2), where he pulled out multiple ECD-interacting partners, including PPRF8
and RUVBL1. Notably, most of the proteins where involved in mRNA processing and are
known to be RNA binding proteins (listed below Table 1, chapter 2). I further categorized
these proteins into different steps of mRNA processing, such as mRNA splicing (PRPF8,
BRR2, EFTUD2) (46), mRNA export (DDX39A, DDX39B and LRPPRC) (18,24,52,53) and
mRNA stability (EEF1A, EIF4A1 and hnRNPU). The focus of my thesis (objectives listed
below) are to understand the role of ECD in mRNA processing.
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Objectives


To examine the role of ECD in mRNA processing



To examine the role of ECD in mRNA export



To examine whether ECD’s role in mRNA export contributes to its oncogenic
function
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Chapter 2

The role of ECD in mRNA export via its interaction with DDX39A
(This chapter is in the modified form of a manuscript that is under
revision in JBC and material and methods is adapted from the same)
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The mammalian ecdysoneless protein interacts with RNA helicase DDX39A to
regulate nuclear mRNA export
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ABSTRACT
The mammalian orthologue of the evolutionarily conserved Ecdysoneless (ECD) protein
is required for embryogenesis, cell cycle progression and mitigation of ER stress.
However, the molecular mechanism of ECD function in mammalian cells remains unclear.
Here, we identified key components of the mRNA export complexes as binding partners
of ECD and characterized the functional interaction of ECD with key mRNA export-related
DEAD BOX protein helicase DDX39A and its associated partners. We find that ECD is
involved in RNA export through its interaction with DDX39A. ECD knockdown (KD) blocks
the mRNA export from the nucleus to the cytoplasm, which is rescued by expression of
full length ECD but not ECD mutant that is defective in interaction with DDX39A. We have
previously shown that ECD is overexpressed in ErbB2+ breast cancers. ECD KD in
ErbB2+ breast cancer cells led to a decrease in ErbB2 mRNA level due to a block in its
nuclear export and was associated with impairment of oncogenic traits.

Given the

essential role of ECD in mouse embryogenesis and ECD overexpression in multiple
human cancers, our findings that ECD is required for efficient mRNA export provide a
novel mechanistic insight into physiological and pathological function of ECD.
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INTRODUCTION
Eukaryotic gene function requires precise coordination of transcription with mRNA
processing, including splicing, capping and polyadenylation, and efficient export through
the nuclear pore complex to transfer the mRNAs to the cytoplasm where the machinery
for translation resides (2,5,14,54,55). The kinetics and efficiency of the export of a mature
mRNA from the nucleus to the cytoplasm require an elaborate export machinery
(3,5,8,15). Key components of this machinery include the nuclear pore complex proteins
(NPCs), RNA binding/non-RNA binding adaptor proteins, chaperones and co-chaperones
inside the nucleus, which help the mRNAs to transverse the nuclear envelope and reach
the cytoplasmic compartment (14,15,54,56,57). Two major mRNA export pathways are
the NXF1 (Nuclear RNA export factor 1)-NXT1 (NTF2-related export protein 1)-mediated
bulk mRNA export pathway and the CRM1/XPO1-mediated selective mRNA export
pathway (10,58-68). Both export pathways function in association with multiple adaptor
proteins that associate with the mRNAs to form the mature messenger ribonucleoproteins
(mRNPs) and help dock the mRNAs to the NPC channels for efficient export
(3,5,64,69,70). The CRM1-mediated mRNA export pathway is more selective and
facilitates the export of ribosomal RNAs, viral RNAs, U-snRNA and other mRNAs using
known as well as undefined adaptor proteins (2,3,5,6,8,14,15,54,55,57,63,71,72).
Given the fundamental role of the mRNA export pathway in cell physiology and the
importance of regulated mRNA transport under varying physiological conditions and
during pathological situations (54,73,74), identification of novel components of the mRNA
export machinery is of great interest. Here, we describe the mammalian Ecdysoneless
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(ECD) protein as a novel structural and functional component of the mRNA export
machinery.
The mammalian ECD is the highly conserved orthologue of Drosophila
ecdysoneless (Ecd) whose mutations lead to developmental arrest due to loss of the
metamorphosis-associated ecdysone hormone secretion during early development.
Drosophila Ecd also functions cell-autonomously in embryonic cell survival and was
previously found to interact with the spliceosome factor pre-mRNA processing 8 (Prp8;
orthologue of the mammalian PRPF8), and loss of Prp8 or Ecd led to defective splicing of
the ecdysone biosynthetic enzyme CYP307A2/spookier (spok) pre-mRNA, providing a
basis for the metamorphosis defects in ecd mutant flies (48). Notably, human ECD could
compensate for loss of Drosophila Ecd for this function.
We have previously shown that germline deletion of Ecd in mice leads to early
embryonic lethality and recombinase-mediated deletion of Ecd in mouse embryonic
fibroblasts (MEFs) from Ecdflox/flox mice or the shRNA-mediated knockdown of ECD in
human mammary epithelial cells led to G1 cell cycle arrest, indicating an essential role of
mammalian ECD in cell cycle progression (38). Recently, using depletion and
overexpression approaches, we have uncovered a role of ECD in mitigating endoplasmic
reticulum stress through ECD-dependent attenuation of the PERK (PRKR-Like
Endoplasmic Reticulum Kinase) branch of the unfolded protein response (45). Others and
we have shown that ECD interacts with the R2TP co-chaperone complex (consisting of
RUVBL1, RUVBL2, RPAP3, and PIH1D1 proteins) which functions in the assembly and
remodeling of multimeric protein-RNA complexes, such as the U5 small nuclear
ribonucleoprotein (snRNP) complex (46,47,75,76). Notably, mammalian PRPF8 also
interacts with ECD (49) and another study found ECD, PRPF8 and R2TP subunits to be
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in a single complex (46). These studies have begun to point to potential roles of ECD in
RNA biogenesis.
The importance of understanding the mechanism of how ECD functions is further
highlighted by studies, by others and us that have demonstrated ECD overexpression in
several human cancers, such as those of pancreas, breast and gastric tumors
(37,40,42,43).

We have shown that ECD overexpression in breast cancer patients

correlates with poor prognosis and shorter survival, especially in the ErbB2+ breast cancer
subtype (42). These studies support the likelihood of ECD’s role in promoting
oncogenesis, a possibility supported by the ability of overexpressed ECD to cooperate
with mutant H-Ras to oncogenically-transform non-tumorigenic immortal human
mammary epithelial cells (44).
Here, we identify components of the mRNA export machinery as interacting
partners of ECD, and show that ECD regulates mRNA export. In ErbB2+ breast cancer
cells, ECD regulates ErbB2 mRNA export and is required for ErbB2+ breast cancer cell
proliferation, anchorage independent growth, and migration and invasion. Thus, our
findings provide a new mechanistic insight into the physiological role of ECD and a
potential basis for how overexpressed ECD may promote oncogenesis.

RESULTS
ECD interacts with components of the mRNA export machinery
Our previous mass spectrometry analysis on ECD from Mir et al., (49) have identified
multiple proteins important in various cellular functions. Interestingly, some of these
proteins are key regulators of nuclear mRNA transport like DDX39A and LRPPRC. In view
of a lack of previous linkage between ECD and mRNA export, studies here focused on
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further characterization of the interaction of ECD with DDX39A RNA helicase, an ECDassociated protein previously established as a critical player in mRNA export (24,25,7779). We have already shown that ECD localizes to both nucleus and cytoplasm and
harbors very strong CRM1 mediated nuclear export signal and with leptomycin B
treatment, ECD is retained in nucleus (36). To confirm the interactions identified by mass
spectrometry we first carried out immunoprecipitations (IPs) of endogenous proteins
followed by Western blotting (WB) for the potential interacting partners. IP from lysates of
HEK-293T cells with antibodies against ECD (Figure.3A) or DDX39A (Figure. 3B) vs.
rabbit [rIgG] or mouse [mIgG] as negative controls) followed by WB for ECD, DDX39A or
CBL (Casitas B-lineage Lymphoma, as an expected non-interacting control) showed that
ECD co-immunoprecipitated with DDX39A and ALY, the latter a known interacting partner
of DDX39A (80) that served as a positive control. Next, we expanded our analyses by
carrying ECD, LRPPRC, CRM1, ALY or IgG IPs from lysates of HEK-293T (Figures. 3C
&D) or MCF10A (a spontaneously immortalized mammary epithelial cell line) (Figure. 3E)
cell lysates and subjected these to WB with antibodies against CRM1, LRPPRC, ALY,
DDX39A or ECD (Figure 3C). Conversely, we performed IP with anti-ECD or anti-DDX39A
followed by WB with antibodies against the various mRNA export-associated proteins
(Figures. 3D & 3E). These analyses demonstrated the association of endogenous ECD
with DDX39A and with its associated protein complex (ALY, LRPPRC and CRM1) in both
cell lines (Figure. 3A-E). Co-IP of CRM1 served as a positive control for LRPPRC IP, as
reported earlier (70) and co-IP of ALY served as a positive control for DDX39A IP.

In the second approach to confirm the interaction of ECD with DDX39A, we carried
out pull-down experiments with GST fusion protein of ECD (amino acids 1-644) or GST
alone (negative control) from lysates of HEK-293T cells transiently transfected to
overexpress FLAG-DDX39A or FLAG-RUVBL1 (known binding partner of ECD) (49). WB
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of pull-downs confirmed the binding of ECD to DDX39A as well as to RUVBL1 (Figure.
3F). Next, to assess the regions of ECD that are required for binding to DDX39A, we used
the pull-downs with GST fusion protein of full length ECD (1-644) vs. its various fragments
(amino acids 1-155, 150-438 or 150-644), and a point mutant ECD-P617G, which is a
conserved proline in multiple organism and also known to cause molting defects in
Drosophila upon mutation to other amino acid (34). The deletion mutants ECD-150-438,
ECD 150-644 pulldown similar to that with full-length ECD (FL-ECD; aa 1-644), while an
N-terminal ECD fragment (ECD 1-155) failed to bind to DDX39A (Figure. 3G), suggesting
that the ECD region encompassing amino acids 150-438 is required for interaction with
DDX39A. Notably DDX39A binding was abolished in the ECD-P617G mutant (Figure. 3G);
however, this point mutant retained the ability to associate with RUVBL1, arguing against
gross misfolding of this protein. The inability of this mutant to bind DDX39A suggests a
potential modulation of ECD-DDX39A interaction by the C-terminal region harboring the
mutation but the mechanism of such modulation remains unclear. Taken together, our
analyses established that ECD interacts with DDX39A and its associated nuclear export
protein complex.

ECD regulates nuclear mRNA export to the cytoplasm
The interaction of ECD with DDX39A and associated proteins involved in mRNA
export supported a potential functional role of ECD in regulating mRNA export from the
nucleus to the cytoplasm. To this possibility, we first examined the impact of ECD
knockdown on mRNA export using the Fluorescence in situ Hybridization (FISH) analysis
of Poly A mRNAs (23,71,78).

Immortal mammary epithelial cell lines MCF10A and

76NTERT were transfected with control siRNA or with two independent siRNAs against
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ECD or DDX39A (used as a positive control) and ECD or DDX39A KD was confirmed by
western blotting (Figure. 4A-F)FISH analysis of the relative abundance of nuclear vs.
cytoplasmic Poly A mRNA revealed that DDX39A KD led to increased nuclear relative
to cytoplasmic Poly A mRNA signals in both cell lines, as expected (23). Notably, similar
to that seen with DDX39A KD, ECD KD also led to a significant increase in nuclear Poly
A mRNA signals (Figure.4B& E). Quantitation of the nuclear/cytoplasmic ratio of Poly A
mRNA FISH signals in 100 or more cells confirmed the nuclear accumulation of mRNA
upon ECD KD (Figure. 4 C& F).
To further validate the negative impact of ECD KD on Poly A mRNA export, we
utilized infected Ecdfl/fl mouse embryonic fibroblasts (MEFs) (38,45) with adenoviruses
encoding either GFP (control; expressed in cytoplasm and nucleus) or GFP-Cre
recombinase (nuclear-targeted) to induce the deletion of floxed-Ecd (38). Western blotting
confirmed the marked depletion of ECD expression in GFP-Cre vs. the control GFP
adenovirus-infected MEFs (Figure. 4G) and immunofluorescence analysis for GFP
confirmed the expression of control GFP in both cytoplasm and nucleus and that of GFPCre in the nucleus (Figure. 4I). Notably, compared to a more uniform nuclear and
cytoplasmic distribution in GFP-expressing control MEFs, a substantial nuclear
accumulation of Poly A mRNA was observed in GFP-Cre (Ecd-deleted) MEFs.
Quantification of the nuclear/-cytoplasmic ratio of Poly A mRNA FISH signals from 25 cells
revealed a significant impact of Ecd deletion (Figure. 4H). Collectively, these analyses
support the conclusion that ECD is required for efficient export of Poly A mRNA from the
nucleus to the cytoplasm.

ECD is involved in DDX39A-dependent mRNA export
Given our findings that ECD interacts with DDX39A and is required for mRNA export, we
wished to examine if the ECD-DDX39A interaction is functionally important for the mRNA
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export function of ECD. First, we assessed if ECD KD had any impact on the levels
DDX39A and other mRNA export-related proteins. ECD KD did not affect the levels or
localization of DDX39A or its associated partners (Figure. 5A-D). Next, we compared the
ability of exogenous ECD or its DDX39A-non-interacting mutant P617G to rescue the
defective mRNA export induced upon Cre-mediated deletion of Ecd in Ecdfl/fl MEFs. GFP
expression was used to identify cells infected with control GFP or GFP-Cre adenovirus
(green cells). Western blotting confirmed the expression of exogenous FLAG-tagged ECD,
ECD-P617G mutant or DDX39A vs. the vector alone transduced cells (Figure. 6A). RNA
FISH analysis for Poly A mRNA showed the expected nuclear accumulation of Poly A
mRNA in GFP-Cre-infected cells transduced with vector alone (Figure. 6B row 2 vs. row
1). Notably, MEFs with Ecd deletion that were transduced with human ECD showed
nuclear/cytoplasmic Poly A mRNA signals comparable to those without Ecd deletion (seen
as red dots in the cytoplasm) (Figure. 6B compare rows 5 & 6), indicating rescue of the
mRNA export block. In contrast, Ecd-deleted MEFs transduced with ECD-P617G mutant
did not show a rescue of the Poly A mRNA export block induced by Ecd deletion (Figure.
3B, compare rows 7 & 8). Notably, expression of exogenous DDX39A expression did not
rescue the mRNA export block induced by Ecd deletion (Figure. 6B, compare rows 3 &4),
indicating that ECD may function downstream of DDX39A in mRNA export. Quantification
of nuclear/cytoplasmic mRNA signals normalized to adeno GFP-transduced MEFs further
transduced with vector alone confirmed significant rescue of Ecd deletion-induced mRNA
export block by human ECD but not by ECD-P617G mutant or DDX39A (Figure. 6C).
Taken together, these results demonstrate interaction of ECD with DDX39A is required
for its positive role in mRNA export and that ECD plays a distinct role that cannot be
fulfilled by DDX39A itself.
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ECD regulates ErbB2 mRNA levels by controlling its nuclear export
While the experiments presented above with non-transformed cells using analyses
of Poly A mRNA export helped demonstrate the general role of ECD in mRNA export,
ECD is known to be overexpressed in breast cancer and such overexpression correlates
with shorter patient survival, especially in ErbB2-overexpressing patients (42). As the
driver oncogene of such tumors, ErbB2 mRNA biogenesis is pivotal for oncogenesis (81)
, we wished to examine if ECD plays a role in ErbB2 mRNA export. First, we transfected
ErbB2-overexpressing SKBR3 and BT-474 or EGFR-overexpressing MDA-MB-468 breast
cancer cell lines with control or two independent ECD siRNAs and then examined the
levels of ErbB2 and EGFR. Knockdown of ECD in both ErbB2-overexpressing cell lines
(SKBR3 and BT-474) as well as in MDA-MB-468 (does not overexpress ErbB2) resulted
in a marked reduction in ErbB2 protein levels (Figure. 7A). On the other hand, there was
no change in EGFR protein levels in either the EGFR-overexpressing MDA-MB-468 cells
or in other two cell lines that express lower basal EGFR levels (Figure. 7A). Notably,
analyses of ErbB2 and EGFR mRNA levels using qRT-PCR showed that ECD knockdown
resulted in drastic reduction in ErbB2 mRNA levels (Figure. 7B). DHFR, an E2F target
gene whose expression we have previously shown to be reduced in Ecd knockout MEFs
(38), served as a positive control. Compared to a marked reduction in ErbB2 mRNA levels,
no reduction was observed on EGFR mRNA levels upon ECD KD (Figure. 7B). Given the
effect of ECD KD on ErbB2 protein and mRNA levels, we assessed the impact of DDX39A
KD on ErbB2 protein and mRNA levels. Notably, DDX39A KD also led to a marked
decrease in the levels of ErbB2 protein (Figure. 8A) and mRNA (Figure. 8B), which was
comparable to the effects of ECD KD.
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To directly assess the impact of ECD or DDX39A knockdown on ErbB2 mRNA
export, we quantified ErbB2 mRNA levels in nuclear vs. cytoplasmic fractions of control
vs. ECD or DDX39A KD cells. The purity of nuclear and cytoplasmic fractions was
confirmed by analyzing the long noncoding RNA MALAT1 (Figure. 8D), which is
predominantly retained and hence abundant in nucleus (82) . The qRT-PCR analyses
revealed a higher nuclear to cytoplasmic ratio of ErbB2 mRNA in ECD or DDX39A KD
cells compared to control KD (Figure. 8E); supporting the conclusion that depletion of ECD
or DDX39A reduces the export of ErbB2 mRNA from the nucleus to the cytoplasm. These
findings were confirmed in ErbB2-overexpressing BT-4T4 cell line (Figure. 8C &F). Next,
we performed ErbB2 mRNA FISH analysis using an ErbB2-specific RNA probe on ErbB2overexpressing SKBR3 cells. Consistent with the ECD requirement for ErbB2 mRNA
export, the ECD KD cells showed an accumulation of the ErbB2 mRNA in the nucleus
(more red dots in the nucleus; Figure. 8G). Quantification of the nuclear vs. cytoplasmic
ErbB2 mRNA signals showed higher nuclear/cytoplasmic ratio of ErbB2 mRNA signals
upon ECD KD (Figure.8H). Taken together, these experiments demonstrate that ECD is
required for ErbB2 mRNA export from the nucleus to the cytoplasm.

Requirement of ECD for oncogenic traits of ErbB2-overexpressing breast cancer
cells
ECD protein is overexpressed in a significant subset of breast cancers and is also
upregulated in other cancers (37,40,42,43), and its overexpression correlates with poor
prognosis and short survival in ErbB2-overexpressing breast cancers (42). Thus, our
findings that ECD is required for the nuclear export of the mRNA for this driver oncogenes
and to maintain high ErbB2 mRNA and protein levels in ErbB2-overexpressing breast
cancer cells suggested the strong likelihood that ECD would be required for ErbB2-driven
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oncogenic traits. We therefore assessed the functional consequences of ECD KD on key
in vitro oncogenic traits of ErbB2-overexpressing breast cancer cell lines. ECD KD in BT474 and SKBR3 cell lines (Figure. 9A), significantly decreased cell proliferation (Figure.
9B&C; significant at days 6, 8, and 10), colony formation (Figure. 9D, E & F; measured
after 10 days of seeding) and anchorage-independent growth as measured by the soft
agar colony growth assay (Figure. 9G & H; measured 21 day after seeding). In addition,
ECD KD cells exhibited a significant decrease in their ability to migrate across Trans-well
chambers (Figure. 10B) and to invade through Matrigel (Figure. 10C). Taken together,
these results demonstrate that ECD is needed for ErbB2 mRNA export and optimal
expression translates into a requirement of ECD for ErbB2-driven oncogenesis.

DISCUSSION

Given the physical separation of the locales of eukaryotic transcription in the nucleus and
translation in the cytoplasm, mRNA export from the nucleus to the cytoplasm is an
essential step in converting the genetic information from DNA into the proteins for various
structural and functional needs of the cell. Therefore, understanding this process is of
fundamental importance in biology. In this study, we provide evidence that Ecdysoneless
(ECD), a protein evolutionarily-conserved from yeast to humans, is required for export of
mRNAs from the nucleus to the cytoplasm.
Others and we have previously established key roles of mammalian ECD as a
positive regulator of cell cycle progression, as a mitigator of endoplasmic reticulum stress
to promote cell survival and its cooperative role in promoting oncogenesis (38,44,45). Key
roles of ECD in cell survival and other biological pathways in other organisms, such as
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Drosophila, have also emerged (34,48). Yet the underlying mechanisms by which ECD
functions in key cellular processes has been unclear especially since ECD’s structure has
remained unsolved and no domains predictive of a mechanistic basis of its function have
been recognized in ECD (75). From our previous Mass Spectrometry analyses of affinitypurified ECD, we identified a number of ECD-associated proteins known to be involved in
mRNA processing (49).The ECD-associated proteins included PRPF8, previously known
to interact with fly and mammalian ECD and to be involved in fly ECD’s role in alternate
splicing of CYP307A2/spookier (spok ) mRNAs a potential basis for the ecdysoneless
phenotype of fly ecd mutants (48). Given its novelty in understanding mechanisms of ECD
function as well as to elucidate a novel aspect of mRNA export, studies presented here
focused on the association of ECD with the mRNA export-associated DDX39A, and the
functional consequences of this interaction for mRNA export as well as downstream
consequences in the context of regulating oncogenic behavior of cancer cells.
We confirmed the interaction of ECD with DDX39A, using immunoprecipitation
followed by western blotting (Figure. 3). DDX39A interacts with a number of additional
proteins such as ALY, LRPPRC and CRM1 that play key role in mRNA export. Indeed,
IP/WB analyses showed that ECD was associated with these DDX39A-interacting proteins
as well (Figure.3). GST-fusion protein pull-down experiments further support a potentially
direct interaction between ECD and DDX39A and use of truncation mutants of ECD
indicates that the middle part of ECD (amino acids 150-438) are key to its interaction with
DDX39A (Figure.3G).

Further detailed mutational analyses will be needed to more

precisely localize the region/motif within ECD that interacts with DDX39A and similar
mutational analyses of DDX39A should be of considerable interest). Notably, a point
mutant (ECD-P617G), modeled after a Drosophila ecd mutant previously shown to cause
molting defects (34), lacked the ability to interact with DDX39A even though the mutation
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is not within the DDX39A-interacting region of ECD. Since this mutant retained the ability,
like wild-type ECD, to associate with RUVBL1 component of the R2TP1 complex (Figure.
3G), it is unlikely that lack of association with DDX39A is due to misfolding of this protein
although structural studies will be needed to rule this out definitively. It is possible that the
conformation adopted by the C-terminal region of ECD impacts the ability of N-terminal
sequences to engage in protein-protein interactions. Notably, our previous analyses using
small angle X-ray scattering (SAXS) analysis of ECD-1–432 and ECD-1–534 fragments
revealed that the first 400 residues of ECD form a globular structure while the adjacent
~100 residues were in an extended cylindrical conformation (75). These structural features
suggesting the flexibility of the C-terminal region and the more compact structure in the
area where DDX39A interacts are consistent with the potential interactions between Nand C-terminal regions of ECD affecting its interactions, in this case with DDX39A.
Consistent with this possibility, ECD interaction with RUVBL1 involves the more proximal
N-terminal sequences (1-155) that are dispensable for DDX39A interaction (Figure. 3G).
The multi-pronged analyses discussed above revealed that ECD exists as a part of protein
complexes previously implicated in mRNA export, strongly suggestive of ECD’s role in
regulating mRNA export. Multiple approaches supported this prediction. Importantly,
examination of the impact of ECD depletion on mRNA export using FISH analyses of Poly
A mRNA (Figure. 4) as well as biochemical fractionations of nuclear and cytoplasmic
mRNA (Figure. 7) showed that ECD is required for mRNA nuclear export. Use of siRNAmediated ECD KD, inducible ECD KD in human cell lines as well as adenovirus-Cre
mediated Ecd knockout in Ecdfl/fl MEFs provided complementary approaches to lend
strong support for a requirement of ECD in mRNA export. Furthermore, restoration of
blocked mRNA export in Ecdfl/fl MEFs subjected to Cre-mediated Ecd deletion by reexpressing exogenous human ECD (Figure.6A &B), further strengthened the conclusion
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that ECD is critical in mRNA export. Notably, overexpressing exogenous DDX39A in Ecddeleted MEFs did not restore mRNA export, suggesting that ECD plays a distinct role in
the mRNA export process. However, interaction with DDX39A appears to be important for
ECD’s role in mRNA export as the ECD-P617G mutant, which did not associate with
DDX39A (Figure. 3G) was unable to rescue the block in mRNA export in Ecd-deleted
MEFs (Figure. 6A & B). Collectively, these results strongly support a novel function of
ECD in mRNA export, in conjunction with DDX39A and its partners. This idea is consistent
with the impact of REF/ALY depletion, which results in mRNAs in the nucleus (83,84),
similar to that seen upon ECD depletion in our studies. Given the association of ECD with
CRM1 and ALY, future studies are warranted to assess the potential CRM1-dependent
vs. -independent roles of ECD in mRNA export since these machinery share many
proteins such as UAP56/DDX39B and HNRNPA1 participates (18,70).
Using genetic knockout studies, we have previously shown a physiological role of
ECD in embryogenesis, cell cycle regulation and cell survival (38,45,49) and Drosophila
Ecd is also critical in embryonic development and cell survival (34). To what extent the
role of ECD in mRNA export is important in its physiological functions remains conjectural
at present and will require further structural and mutational information that might
selectively eliminate its mRNA export vs. other functions, such as its role in mitigating ER
stress (45), roles mediated through interactions with the R2TP complex and others. In the
context of mRNA processing itself, which involves integrated events including
transcription, capping, splicing, transport and other processing events to allow the
availability of translation-ready mRNA in the cytoplasm (2,3,5,12), it will be of considerable
interest to determine to what extent the new role of ECD in mRNA export we describe
here is linked to or distinct from its PRPF8-dependent role in mRNA splicing (48) and
possibly other RNA processing steps. ECD’s previously established interaction with the
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PIH1D1 and RUVBL1 components of the R2TP co-chaperone complex (composed of
PIH1D1, RPAP3, RUVBL1 and RUVBL2 proteins) (49) may allow it to play an even
broader role in RNA biogenesis. The R2TP complex is known to promote the assembly
small nucleolar ribonucleoproteins (snoRNPs) (46,47,85-90) Notably, ECD was also
reported to interact with ZINHIT2 protein, which was shown to function as a mediator of
R2TP/Prefoldin-like co-chaperone interaction with

the U5 snRNP (47,89), a central

component of the spliceosome (46). Thus, ECD-R2TP complex could play a role in
promoting mRNA splicing. Our current studies links ECD with multiple mRNA processing
proteins involved from splicing to translation of mRNA and indicating future studies will
help decipher a potential role for ECD-R2TP interaction in mRNA export, splicing and
possibly other aspects of RNA biogenesis.
ECD is overexpressed in multiple cancers (40,42,43). As heightened metabolic,
migratory, proliferative and other requirements of cancer cells require increased demand
on mRNA processing for both driver oncoproteins and general biochemical pathways
(11,53,91-96), one mechanism by which overexpressed ECD may contribute to oncogenic
drive is to ensure efficient mRNA export that is linked to aid and enable oncogenesis (96).
In breast cancer ECD overexpression correlated with shorter survival particularly in ErbB2overexpressing patients (42). As ErbB2 overexpression in most breast cancer patients
represents increased transcription from an amplified ErbB2 gene locus (97), the oncogenic
drive is likely to depend on efficient processing of the mRNA for the driver oncogene
ErbB2. Our analyses demonstrate that ECD is indeed critical for ErbB2 mRNA export and
controls the levels of ErbB2 mRNA as well. ECD siRNA-mediated knockdown in ErbB2overexpressing breast cancer cell lines demonstrated that ECD KD markedly reduced the
levels of ErbB2 mRNA but not the levels of EGFR mRNA even in cancer cell line with
EGFR overexpression (Figure. 7B). Use of an ErbB2-specific mRNA probe for FISH
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analyses, we demonstrated a requirement of ECD for ErbB2 mRNA nuclear export
(Figure.8 A-F). Analysis of mRNA levels in cytoplasmic and nuclear fractions further
demonstrated the requirement of ECD for ErbB2 mRNA export and also demonstrated a
requirement for DDX39A (Figure.8D), consistent with the DDX39A-dependent role of ECD
concluded from studies discussed above. It is likely that the marked reduction in ErbB2
mRNA levels upon ECD or DDX39A KD reflects destabilization of ErbB2 mRNA secondary
to its nuclear retention, as nuclear export block is known to trigger degradation of certain
mRNAs (98). ECD-dependent ErbB2 mRNA export is functionally relevant in the context
of overexpressed ECD in cancer cells, is supported by our observations that KD of ECD
dramatically reduced the cell proliferation, anchorage-independent growth migration and
invasion in ErbB2-overexpressing breast cancer cell lines (Figure. 9&10). These results
are consistent with our previous results that ECD provides a co-oncogenic function with
mutant Ras protein to fully transform the non-tumorigenic immortal human mammary
epithelial cells (44). Consistent with the role of ECD in helping to promote the oncogenic
drive in breast cancer cells, overexpression of DDX39A was reported to regulate growth
and metastasis of various cancer types (53,79,80,92-94). Other studies have shown that
DDX39A is also required to maintain the genome integrity and telomere protection,
processes that are rendered aberrant as cells become cancerous (99-102).
Taken together, our studies reveal a novel role of ECD as a required component
of the mRNA export.

Using ErbB2-overxpressing breast cancer cell lines, we implicate

ECD as a regulator of ErbB2 mRNA export and levels as well as oncogenic traits driven
by ErbB2. Given the importance of ECD in cell cycle, cell survival and embryogenesis,
and its overexpression across human cancers, our findings provide a new mechanism that
could help understand the physiological and pathological roles of ECD.

32

Experimental procedures:
Biochemical reagents: Formaldehyde solution (F8775), Doxycycline (DOX, D9891),
Puromycin (P8833), Triton x-100 (T9284), IGEPAL CA-630 (NP-40, I3021) were from
Sigma-Aldrich. Hygromycin B (10687010) was purchased from ThemoFisher scientific.
ANTI-FLAG M2 Affinity Gel (A2220) FLAG peptide (3X FLAG, F4799) Met-Asp-Tyr-LysAsp-His-Asp-Gly-Asp-Tyr-Lys-Asp-His-Asp-Ile-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys

was

from Sigma-Aldrich. Glutathione-Sepharose-4B beads (17-0756-01) and PreScission
Protease (27-0843-01) were from GE healthcare.
Antibodies: Mouse monoclonal antibody against ECD has been previously described
(38,42) . The details of antibodies used in this study are included in information table 1.
Cell Culture, Reagents, and Transfections/Infections: Immortal human mammary
epithelial cell lines (hMECs) MCF10A and 76NTERT were cultured in DFCI-1 medium
(44,45). HEK-293T cells (ATCC) were maintained in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum (36). Adenoviruses encoding
enhanced green fluorescent protein-Cre (adeno-GFP-Cre) or enhanced green fluorescent
protein (adeno-GFP; control) were purchased from the University of Iowa Gene Transfer
Vector Core. For ECD knockout studies, previously published Ecdfl/fl MEFs were
maintained in DMEM supplemented with 10% fetal bovine serum and infected with control
or GFP-Cre as described previously (38,45). For tetracycline (TET)-inducible ECD
overexpression, a full-length human ECD cDNA was cloned into the pRev-TRE (Hygro)
retroviral vector downstream of the tetracycline response element (TRE). Constructs
containing ECD or the empty vector or the pMSCV-rtTA construct encoding the reverse
tetracycline trans-activator were transfected into the Phoenix Amphotropic (AMPHO)
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packaging cell line using a standard calcium phosphate transfection protocol to generate
retroviral supernatants. The pRev-ECD or pRev control retroviruses were co-transduced
with pMSCV-rtTA virus into MCF10A cells using three serial infections with the retroviral
supernatants at 12h intervals followed by selection with 2 µg/ml puromycin and 3 µg/ml
hygromycin for 48 h or until all uninfected cells died. To induce the ECD overexpression,
(vector) or ECD-overexpressing MCF10A cell lines were cultured with 1 µg/ml of
doxycycline (DOX), as published previously (45). SKBR3, BT-474 and MDA-MB-468
breast cancer cell lines were purchased from ATCC (Manassas, VA). SKBR3, BT-474
cultured in RPMI medium supplemented with 10% fetal bovine serum. MDA-MB-468
breast cancer cell line and Mouse embryonic fibroblast cells (MEFs) were cultured in
DMEM with 10 % serum (103). Mycoplasma contamination was examined by DAPI
staining/ fluorescence microscopy. For siRNA-based knockdown, cells were transfected
with 30 nM of the control or the gene-specific siRNAs using the DharmaFECT 1
Transfection Reagent (T-2001-03, Dharmacon, and Pittsburgh, PA) (Details of siRNA is
in information table 2).
Generation of ECD shRNA knockdown cell lines: ErbB2-overexpressing breast cancer
cell lines, SKBR3 and BT-474 were infected with retroviral supernatants corresponding to
two distinct ECD shRNAs or a control shRNA, as described previously (43). Virally
transduced cells were selected in 0.5 μg/ml puromycin for 3 days, and the expression of
endogenous ECD was assessed in whole cell lysates using Western blotting with an antiECD monoclonal antibody (38,42,44).

CellTiter-Glo® Luminescent cell viability assays: 2,000 cells of SKBR3 or BT-474 cell
lines expressing the control or ECD shRNAs were seeded per well in 96-well plates
(Thermo scientific, Cat: #136101) and cultured with change of medium on alternate days.
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At the indicated times, viable cells were quantified using the CellTiter- Glo® luminescent
cell viability assay according to the manufacturer’s protocol (Promega).

Colony formation assays: SKBR3 and BT-474 cell lines expressing the control or two
distinct ECD shRNAs were plated (10,000 cells per well) in six-well plates for 9 days with
change of medium on alternate days. The cells were then fixed and stained with 0.25%
crystal violet (in 25% methanol) and then imaged, as described previously (103) . Pictures
were taken and colonies were counted manually.

Anchorage-independent growth assays: 20,000 cells suspended in RPMI medium
containing 0.3% agarose were seeded on top of a bottom layer of 0.6% agarose in 6-well
plates, as described previously (103,104). Each cell line was plated in triplicates, and each
experiment was repeated three times. Cultures were fed every 2 days. Twenty-one days
after cell seeding, the plates were fixed, and stained with 0.05% crystal violet in 25%
methanol. Pictures were taken and colonies were counted manually (104).

Transwell Migration and Invasion assays:

For migration assays, BT-474 cells

transiently-transfected with control or ECD-specific siRNAs (described above) were
serum-starved in medium with 0.1% FBS for 24 hrs, and 10,000 cells were plated in top
chambers of BD BioCoat Transwell chambers (Cat. # 354578; San Jose, CA). After 2 h,
10% FBS-containing medium was added to bottom chambers. Migration was then
assessed after 24 h by removing the non-migrated cells on the top surface of filters,
fixation in ice-cold methanol and staining with propidium iodide, as previously described
(44). The filters were mounted on coverslips and migrated cells on the bottom surface
observed at 10X magnification under Rhodamine filter using a 710 LSM confocal
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microscope. Invasion assay was performed as for the migration assay, except for the use
of BD Matrigel invasion chambers (#354480) (San Jose, CA).
Immunoprecipitation and immunoblotting: For immunoprecipitations, cell extracts
were prepared in Triton lysis buffer (20 mM Tris-HCl [pH7.5], 200 mM NaCl, 1% Triton-X
100 and a protease inhibitor cocktail from Roche) and protein concentration was
determined using the Bicinchonic acid assay (Pierce™ BCA Protein Assay Kit, 23225).
One mg aliquots of lysate protein immunoprecipitated with 5 µg of antibodies overnight at
4°C. The immune complexes were captured with protein A/G agarose (sc-2003, Santa
Cruz Biotechnology) for an additional 2 h. Samples were prepared by boiling the beads in
2X sample buffer and was loaded in SDS-PAGE gels, and the gels were transferred to
Immobilon Transfer membrane (Millipore, IPVHOOO10) and blotted with corresponding
antibodies and developed with Enhanced chemiluminescence substrate (Perkin Elmer,
NEL05001EA).

GST pull-down assays: GST fusion proteins of ECD or its mutants were purified from
bacterial lysates using Glutathione-Sepharose 4B, and GST pull down experiments were
performed, as described previously (38,49)

RNA Isolation and Quantitative Real Time PCR: Total RNA was isolated from control
and siRNA treated SKBR3 and BT474 cell lines using the TRIzol reagent (Invitrogen™
Catalog # 15596018.), according to the manufacturer’s protocol. 1 μg RNA was reverse
transcribed using SuperScriptTM II reverse transcriptase (Invitrogen, Thermo Fisher
Scientific, Waltham, MA) and oligo-dT primers (18-mer) and aliquots used for quantitative
real-time PCR (qRT-PCR) analyses with specific primer sets (Sigma, St. Louis, MO) listed
below. qRT-PCR was carried out in an Applied Biosystems 7500 Real Time PCR system
using Power SYBR Green master mix from Applied Biosystems (Thermo Fisher Scientific,
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Waltham, MA). Primers used for the manuscript

including ECD (36) is provided in

information table 3.
RNA Fluorescence in situ hybridization (FISH) analysis: Cells seeded on coverslips
were transfected with control or siRNAs against ECD and DDX39A, cultured for 72 h, and
fixed with RNase-free 3.7 % formaldehyde and permeabilized in 70% RNase-free ethanol
overnight at 40C. The coverslips were pre-hybridized for 5 min (with wash-A buffer from
the Stellaris®, LGC Biosearch Technologies kit) and hybridized with 12.5 μM oligo dTQuasar 570 (22 nt –oligo dT custom probe in hybridization buffer (Stellaris®, LGC
Biosearch Technologies) for 4 h at 370C in dark. The coverslips were incubated with wash
A buffer for 30 min at 370C in dark and WASH B buffer at room temperature for 5 min,
according to the manufacturer’s instructions.

The coverslips were mounted with

VCTASHIELD-DAPI mounting media and the imaged using the LSM 710 confocal
microscope under a 63 X lens. For ErbB2 FISH, we used probe (#VSMF-2102-5) from
Stellaris®, LGC Biosearch. Quantification of nuclear vs. cytoplasmic fluorescence was
done using the Intensity Ratio Nuclei Cytoplasm plugin in the Image J software (described
Figure 11 A &B and the legend).
RNA localization by nuclear/cytoplasmic fractionation of cells: After specified
treatments, cells were trypsinized, counted, and divided into two equal aliquots (one for
total RNA isolation and the second for nuclear and cytoplasmic fractionation). Both cell
aliquots were lysed on ice in cell lysis buffer for 10-20 min. For nuclear/cytoplasmic
fractionation, the lysate was centrifuged at 14,000 rpm to collect the nuclear pallet and
soluble. The fractions as well as the lysate for total RNA isolation was treated with buffer
G (RNA isolation kit catalog number 25501, Active Motif) in 70% ethanol, loaded on to
spin column and followed by centrifugation, retained precipitate washed with ethanol for
one time and was eluted in RNase free water. cDNAs were prepared from various RNA
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preparations and qRT-PCR was performed. (As mentioned earlier). mRNAs from nuclear
and cytoplasmic fractions were normalized to total RNA isolated from an identical number
of cells.
Statistical Analysis: Each assay in our study was repeated at least three independent
times. Comparisons between two groups were made using t-tests for continuous
outcomes. Comparisons among at least three treatment groups were made using oneway analysis of variance (ANOVA) for continuous outcomes. If the overall tests yielded
significant results, post-hoc tests with Tukey method for multiple comparisons were
conducted. Log10 transformations were applied to continuous outcomes to meet ANOVA
or t-test assumptions as necessary. p values of ≤0.05 were considered statistically
significant. Data analysis was performed using SAS version 9.4 (SAS Institute, Cary, NC,
United States) and GRAPH pad prism
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Table 1. Selected list of ECD interacting proteins. Various Columns show gene identifier
information; corresponding protein, molecular weight, and Mascot score for association of
indicated protein with ECD.
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Figure 3. ECD interacts with DDX39A and other components of the mRNA
export machinery. (A-D) HEK-293T or (E) MCF10A cell lysates were
immunoprecipitated (IP) with the antibodies indicated at the top, followed by
western blotting (WB) with the antibodies shown on the left side. ALY and CRM1
were used as positive controls. CBL, Mouse IgG (mIgG) and rabbit IgG (rIgG) were
used as negative controls. 100 µg aliquots of lysate protein was used in the input
lane. (F) 20 µg of GST (negative control) or GST fusion with full length ECD (1644 aa) were incubated with 1 mg of protein lysate from HEK-293T

cells

transfected with FLAG-tagged RUVBL1 or FLAG tagged DDX39A and the GSTpull down proteins were analyzed by western blotting with the indicated antibodies.
The membrane was stained with Ponceau S to visualize the GST fusion proteins
to assess comparable fusion protein use for pull-downs (indicated by arrows). (G)
GST or GST fusion with full length ECD (1-644) or indicated ECD mutants were
incubated with protein lysate of HEK-293T cells transiently transfected with FLAG
tagged-DDX39A and FLAG tagged RUVBL1, and the bound proteins were
analyzed by western blotting with the indicated antibodies. The membrane was
stained with Ponceau S to visualize the GST fusion proteins (indicated by arrows).
The experiment shown is a representative of at least three repeats with
comparable results.
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Figure. 4 ECD KD decreases Poly A mRNA export from the nucleus to the
cytoplasm. RNA FISH analysis on MCF10A (A-C) OR 76NTERT (D-F) cells with
Control siRNA (Ctl, as negative control), two independent siECD (#1 and #2) or
siDDX39A (as positive control). (A/D) WB shows ECD or DDX39A KD. (B/E) Cells
were fixed and hybridized with 12 µM of oligo dt-22nt quasar 570 probe, and then
imaged using 710 LEISS confocal microscope at 63X magnification. Last column
shows enlarged view of cells shown in the insert. (C/F) Quantification of nucleus
to cytoplasmic (N/C) signals was done using Image J software in at least 100 cells
and graphs were plotted by normalizing to the control cells to calculate the fold
change. (G-I) ECDfl/fl cells were either treated with GFP (control) or Cre-GFP
adenovirus to delete ECD, (G) WB shows cre-mediated knockdown of ECD, βactin used as a loading control. (H/J) Cells were fixed and imaged as discussed
above. (I) Quantifications of at least 25 cells using ImageJ measuring nucleus to
cytoplasmic signals ratio (N/C) by normalizing to the control cells to calculate the
fold change is presented. Significance of the ratios were calculated using Student’s
two-tailed t-test and are indicated by ∗=P ≤ 0.05, error bars represent standard
error from the mean. Mean± S.E was derived from three different experiments.
Scale bar is 10 µm.
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Figure 5.
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Figure 5 ECD KD did not affect the levels or localization of DDX39A and its
associated partners. (A) (A) Endogenous ECD was deleted using ECD siRNA collected
at different time points (48h, 72h, 96h) in MCF10A cells . Cell lysates were then subjected
to western blotting with indicated antibodies (B-D) Cells from experiment A were fixed in
4% PFA and subjected to immunostaining using indicated antibodies followed by imaging
using 63X LEISS confocal microscope (scale bar 10 µm.
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Figure. 6. ECD interaction with DDX39A is required for mRNA export.
RNA FISH analysis was performed on Ecd
either vector,

fl/fl

MEFs (A-C) overexpressing

ECD, DDX39A and ECD-P617G after treatment with GFP

(control) or Cre-GFP adenovirus to delete ECD. (A) WB shows Cre-mediated
knockdown of ECD, Exogenous ECD indicated by red arrows. β-actin was
used as a loading control. (B) Cells were fixed and hybridized with 12 µM of
oligo dt-22nt quasar 570 probe, and then imaged at 63X magnification. (C)
Quantifications of nucleus to cytoplasmic signals were done using ImageJ
software in at least 100 cells and graphs were plotted by normalizing to the
control cells. Significant difference of ratios among groups was determined
using ANOVA (all Tukey’s adjusted p-value between each of other groups and
the control group less than 0.05 ) ∗=p ≤ 0.05 ,∗∗ =p ≤ 0.01, ∗∗∗ =p ≤ 0.001
bars represent standard error from the mean. Mean± S.E was derived from
three different experiments. Scale bar is 10 µm.
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Figure. 7. ECD KD decreases ErbB2 protein and mRNA expression in breast cancer
cells. ECD knockdown was performed using specific siRNA against ECD in BT-474,
SKBR3 (ErbB2-overexpressing) and MDA-MB-468 (EGFR-overexpressing) breast cancer
cell lines. Protein and total mRNA were isolated after 48 hour of transfection. (A) Lysates
were harvested and immunoblotted with indicated antibodies. β-actin was used as a
loading control. (B) Control mRNA levels of ECD, ErbB2 or EGFR were detected by qRTPCR; DHFR was used as a positive control and GAPDH served as an internal control.
Fold change over GAPDH was calculated and plotted and normalized with control.
Significance of the ratios were calculated using Student’s two-tailed t-test, ns= not
significant, ∗=p≤0.05; ∗∗=p≤0.01, ∗∗∗=p≤0.001 error bars represent mean +/- SD of six
replicates in a representative experiment. The experiment was repeated three times
independently
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Figure 8
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Figure. 8.

ECD KD increases nuclear ErbB2 mRNA accumulation. (A-G)

SKBR3/BT474 cells were transfected with control siRNA, ECD siRNA and DDX39A
siRNA. (A) Western blotting was performed with indicated antibodies; β-actin was used
as a loading control, confirming knock down of ECD and DDX39A. (B) qRT-PCR shows
decrease in ErbB2 mRNA in ECD/DDX39A KD cells in comparison to control siRNA
treated cells. The graph plotted shows ECD, ErbB2 and DDX39A mRNA levels normalized
to β-actin, and fold change was calculated by normalizing to control. (C) qRT-PCR of
MALAT1 (a long noncoding RNA) used as control for purification of nuclear fraction. (D)
Subcellular RNA fractionation of control siRNA or ECD siRNA or DDX39A siRNA
treatment followed by qRT-PCR of ErbB2 mRNA showing nuclear cytoplasmic ratio (N/C).
(E&F) ECD knockdown was performed using specific siRNA against ECD in SKBR3 cells.
(H) RNA FISH analysis was carried out with 12 µM of oligo anti ErbB2 570 probe, and
then imaged at 63X magnification, last column shows enlarged view of cells. White
arrowheads shows the accumulation of ErbB2 mRNA probe. Scale bar is 10 μm. (I)
Quantifications of at least 25 cells using ImageJ showing nucleus to cytoplasmic ratio
(N/C) by normalizing to the control cells to calculate the fold change is presented.
Significance of the ratios were calculated using Student’s two-tailed t-test and are
indicated by ∗=p ≤0.05, error bars represent standard error from the mean. Mean± S.E
was derived from three different experiments.
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Figure 9
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Figure.

9

ECD

Knockdown

decreases

cell

proliferation

and

anchorage

independence of ErbB2 overexpressing breast cancer cells. (A) ECD was stably
knockdown by two different shRNAs against ECD and then KD was assessed by western
blotting. (B &C) Cell proliferation assays were performed using CellTiter-GLO luminescent
cell viability assay; 2000 cells per well were plated (as discussed in material and methods
section). Readings were taken at indicated days and log10-transformed to meet ANOVA
assumptions. Graphs were plotted based on the mean of log10-transformed readings for
each group at each time point. The corresponding standard errors were very small and
not plotted. Analysis with ANOVA indicated that mean log10-transformed readings of the
control group was higher than those of both ECD sh1 and ECD sh2 at day 6, 8, and 10
(all Tukey’s adjusted p-value less than 0.0001). (D) For colony formation assay 10,000
cells were plated in 6 well plate and colonies were fixed and then stained with crystal violet
after 10 days of plating. Colonies were counted and presented as histogram for BT-474
(E) and SKBR3 (F) cells. Analysis with ANOVA indicated that mean number of colonies of
the control group was higher than those of both ECD shRNA#1 and ECD shRNA#2 (all
Tukey’s adjusted p-value less than 0.001). (G & H) Soft agar colony formation assay was
used to measure anchorage dependence. 20,000 cells were plated in 0.3% agarose in 6well plates for 21 days (described in detail in materials & methods section) and then
colonies were stained with 0.05% crystal violet. Colonies were counted and plotted as
histograms for BT-474 (G) cells and SKBR3 (H) cells. Analysis with ANOVA indicated that
mean number of colonies of control in soft agar was higher than those of both ECD
shRNA#1 and ECD shRNA#2 (all Tukey- adjusted p-value less than 0.001). ∗=p≤0.05,
∗∗p=≤0.01, ∗∗∗=p≤0.001 and ns=non-significant. Mean± S.E was derived from three
different experiments each done in triplicates.
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Figure 10.
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Figure. 10. Knockdown of ECD decreases invasion and migration ability of breast
cancer cells. BT-474, an ErbB2 positive breast cancer cell line were treated with control
or two independent siRNA against ECD. (A) Western blotting shows knockdown of ECD
with two independent siRNAs. 10,000 cells were counted and plated on Boyden chambers
for assessing their ability to migrate (B) and invade (C). After 24 hrs, cells that had invaded
through Matrigel (for invasion assay) and migrated to the bottom surface were fixed and
stained with propidium iodide. Pictures were taken, cells were counted, and histograms
were plotted. The bar diagrams represent number of cells migrated or invaded. Analysis
with ANOVA indicated that mean number of cells migrated of the control group was higher
than those of both ECD siRNA#1 and ECD siRNA#2 (all Tukey’s adjusted p-value less
than 0.001), ∗=P ≤0.05; ∗∗P ≤ 0.01, ∗∗∗ =p ≤ 0.001 and ns = non-significant. Mean± S.E
was derived from three different experiments each done in triplicates.
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Figure 11
A.

B.
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Figure 11. Quantification using Image J plugin Intensity Ratio Nuclei
Cytoplasm Tool. (A) Shows representative image of poly A mRNA FISH form CTL
siRNA treated cells. Raw images are converted to 8 bit and color threshold was
adjusted with hung method for every image. Using background correction tool (cbutton) was used DAPI channel to select the nucleus and intensity was measured
in single channel for red channel. Icn factor, the factor between the cytoplasm and
the nuclei intensity (%nuclei = %cytoplasm), was used for calculating the ratio for
control v/s corresponding treatment. (B) Depicts selection of nuclei in each cells
after background correction.
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Table 2. List of antibodies used in the manuscript.
Antibody

Catalogue number

Company

DDX39A

ab96621

Abcam

DDX39A

sc-271395

Santa Cruz

PRPF8

ab79237

Abcam

LRPPRC

ab97505

Abcam

CRM1

46249

Cell signaling

ErbB2

2242S

Cell signaling

CBL

610442

BD Bioscience

ALY

ab202894

Abcam

FLAG

F3165

Sigma Aldrich

Alexa Fluor 488

A32731

Thermo Fisher Scientific

Alexa Fluor 488

A32723

Thermo Fisher Scientific

Alexa Fluor 568

A-11011

Thermo Fisher Scientific

Alexa Fluor 568

A-11031

Thermo Fisher Scientific
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Table 3. List of siRNAs used in the manuscript.

Gene

siRNA

Sequence/ catalogue number

Company

name
ECD

siECD#1

5’-AAGGCCTAATGAGTCAGATTCdTdT -3’

Dharmacon

ECD

siECD#2

5’-AAGAACCAAGUGGAACCUGUAdTdT-3’

Dhamacon

sc-77111

Santa Cruz

DDX39A
siDDX39A

Table 4. List of primers used for RT PCR in the manuscript.
GENE

Forward Primer

Reverse Primer

ECD

ACTTTGAAACACACGAACCTGGCG

TGATGCAGGTGTGTGCTAGTTCCT

DHFR

TAAACTGCATCGTCGCTGTGT

AGGTTGTGGTCATTCTCTGGAAA

ErbB2

AGCCTTGCCCCATCAACTG

AATGCCAACCACCGCAGA

EGFR

TGCCATCCAAACTGCACCTA

CTGTGTTGAGGGCAATGAG

GAPDH

GTCATCCATGACAAGTTTGG

TGCCAGTGAGCTTCCCGTTC
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Chapter 3

ECD is a potential RNA binding protein
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ECD is a highly conserved protein, as we discussed earlier drosophila ECD harbors about
30 % similarity with both human, mouse, and 21% similarity with yeast. Human ECD is
644 amino acid containing protein(34); however, concurrent motif and domain analysis
have not identified any strong motifs or domain present in ECD. So far biophysical analysis
done previously by our lab have shown that ECD have highly globular N-terminal domain
through small angle X-ray scattering, SAXS analysis, however there is limited information
about C-terminus of ECD(49). Thus far C –terminus of ECD have shown to have highly
acidic amino acid (A.D) (Figure 12 A, ) rich region (502-532), (38)and a region possibly
required for transactivation function of ECD. Apart from that another study from our lab
have shown that the region 481-497 (Figure 12 A), could be possibly a nuclear export
signal (NES) that keeps ECD outside nucleus through CRM1 mediated export(51).
Further bioinformatics analyses of ECD have predicted that ECD has

an intrinsically

disordered region in the C-terminus. However, lack of any canonical motif was limiting for
our understanding about the role of ECD in mRNA processing. We have already tested
whether ECD regulates the localization or levels of the protein it interacts with (Figure 5AD) and as we have shown above ECD does not affect the levels or localization of these
proteins. It remained an open-end question how ECD functions as a key regulator of
mRNA export. Although multiple domain analysis have shown that ECD does not harbor
any canonical RNA binding domain, some RNA binding prediction software predict ECD
is a potential RNA binding protein. Taken into consideration above studies, we examined
if ECD is capable of binding to mRNA.(105)

Material and methods
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RNA Electrophoretic Mobility Shift Assays (EMSA)

Purification of proteins for RNA EMSA: GST fusion proteins of ECD were expressed in
E.coli, purification and cleaving of GST tag using precision protease was performed as
discussed above. DDX39A (Myc-DDK-tagged) in pCMV6 vector was purchased from
Origene (CAT#: RC201759), subcloned into pFastbac1- c-terminal his tag vector and then
baculovirus purified DDX39A was generated by the Viral vector core and Protein &
Crystallography Facility core (University of Iowa). HEK-293T cells were transfected with 1
µg of FLAG tagged ECD or DDX39A and anti-FLAG affinity purification was performed
as discussed above to obtain mammalian cell purified ECD and DDX39A.
RNA EMSA using the Light Shift™ Chemiluminescent RNA EMSA Kit (Thermo Fisher,
catalog number 20158) was performed as per the manufacturer’s protocol. Biotinylated or
non-biotinylated

single

stranded

42

mer

RNA

probe

(5'-

AGCGUGCCGUGCAACAACAUUACAAUUUACAAUCCACCAUGG-3’) previously used
to detect DDX39A (53,80) . RNA probe was incubated in EMSA binding buffer with/without
purified ECD, baculoviral purified DDX39A, FLAG-tagged ECD or DDX39A. The samples
were resolved on 7.5 % native PAGE gels, transferred to H-bond membrane (Amersham
Hybond-N+, RPN119B) and then developed with Streptavidin-HRP, according to the
manufacturer’s instructions (Light shift chemiluminescence RNA EMSA kit from
ThermoFisher).
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Results.

ECD directly binds to RNA
The interaction of ECD with components of the mRNA export machinery raised the
question

whether

ECD

binds

to

RNA.

The

domain

prediction

algorithm

(https://prosite.expasy.org/cgi-bin/prosite/PSScan.cgi) did not reveal any canonical RNAbinding domains/motifs in ECD. To experimentally assess if ECD binds to RNA, we used
an in vitro RNA EMSA assay to examine the ability of purified ECD to bind to a biotinylated
42-mer single-stranded RNA probe, previously used to demonstrate the RNA binding of
DDX39A (53).
For these analyses, ECD protein was purified from GST-ECD fusion proteins using
precision protease cleavage to remove the GST portion (Figure. 12B). Biotinylated 42-mer
single stranded RNA probe was incubated without or with increasing concentrations (5 15 µg) of purified ECD to assess its binding with mRNA probe(mobility shift of the probe).
Baculovirus-purified His-tagged DDX39A was used as a positive control. As expected,
purified DDX39A showed binding to labeled RNA probes, which was eliminated by an
excess of unlabeled probe (Figure. 12C, compare lanes 2 and 6). Notably, ECD (Figure
12 Ccompare lanes 3-5 with lane 1) showed dose-dependent RNA binding and this
binding was competed out by the unlabeled probe (Figure 12C lane 7). To confirm RNAbinding with mammalian cell-expressed ECD, we expressed FLAG-tagged ECD or
DDX39A (used as a positive control) in HEK-293T cells followed by anti-FLAG affinity
purification. RNA EMSA analysis with increasing concentrations (0.2 to 8 µg) of purified
FLAG-DDX39A or FLAG-ECD demonstrated FLAG-ECD dose-dependent RNA–ECD
complex formation (Figure 13D lanes 2 to 5), similar to that seen with purified FLAG-
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DDX39A (Figure 12D lanes 6 to 9). Overall, our results demonstrate that ECD is capable
of directly binding to RNA, a property consistent with its potential role in mRNA export.

Deletion of acidic domain region enhances the binding of ECD to RNA
Next, we generated different His tagged 1-432 and His-tagged 1-567 mutants of ECD
as well as GST-fusion protein cleaved purified FL-ECD1-644, P617G and Acidic Domain
(AD) deletion mutant of ECD to analyze the capability of different mutants of ECD to bind
RNA using EMSA assay. Notably, deletion of the acidic domain region enhanced the
binding of ECD to RNA (Figure 13 lane 6 to 8) in comparison to purified full length ECD
(lane 3 to 5). Whereas, purified ECD P617G (Figure 13 B, lane 6 to 8) did not show much
difference in RNA binding in comparison to purified full length ECD (Figure 13B, lane 3 to
5). This region has been shown to have the DSDD motif by Hořejší et al (50). In addition,
we have shown earlier that phosphorylation at this specific region is important for cell cycle
function of ECD (49).
Further we observed that His-purified 1-432 and 1-567 (Figure 13 C) were able to bind
RNA, which suggests RNA binding domain is towards the N-terminus of ECD (Figure 13
D). Further we examined two a putative zinc finger region (Δ302-326), which is similar
as COE1 transcription factor (106) (Figure 13 E &G) and a putative ATPase region that
is predicted in drosophila ECD (Δ554-562) (34) (Figure 13 E &F). EMSA analysis showed
none of these mutations altered RNA binding capability of ECD.

Discussion
There is ample body of literature demonstrating that RNA binding proteins are the master
regulators of mRNA processing. Given the important role of RNA binding proteins in the
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regulation of gene expression, splicing regulation, mRNA export and translation, it was of
importance to demonstrate if ECD binds to RNA. Furthermore, it has been shown that
RNA binding proteins are overexpressed in cancer and play an important role in cancer
progression. As detailed in the introduction ECD is an oncogenic driver and therefore it is
of high significance to demonstrate ECD is an RNA binding protein.

As detailed in my thesis, majority of proteins that interact with ECD exhibit RNA binding
activity. Furthermore ECD interacts with proteins that are involved in mRNA processing,
such as DDX39A is a well-known nuclear export regulating protein and PRPF8 is a major
protein involved in pre-mRNA to mRNA splicing. This prompted us to examine if ECD is a
RNA binding protein.
As we demonstrate GST purified ECD and its mutants are capable of binding to RNA
(Figure 12 and 13). Our mutational analysis so far has not yet identified the RNA binding
domain on ECD, and a comprehensive mutational (deletion and point mutants) is currently
underway to define the exact amino acids in ECD required for its RNA binding activity.
This is a priority research currently in the laboratory as to address if RNA binding activity
of ECD is required for various functions seen so far the role of ECD in nuclear export, premRNA to mRNA conversion as well as role in splicing. Furthermore, we have shown ECD
deletion/depletion induces cell cycle arrest and triggers ER stress, suggesting those
functions may also be linked to its RNA binding function.. While our data shows that ECD
binds to RNA, we do not know yet the selective or specific RNAs that bind to ECD, a future
direction of my mentor’s laboratory. . My mentor’s laboratory have performed ECD
depletion in several cell lines followed by RNA sequencing analysis and have observed
ECD depletion alters a large number of RNA expression but there are some RNAs whose
levels were unchanged, suggesting ECD may bind and affect selective RNAs. We plan to
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perform RNA immunoprecipitation or iCLIP followed by RNA sequencing analysis to
address these questions.
Notably, alignment search against PDB database showed similarity between ECD and
multiple RNA binding proteins; however, most of these regions are not so far well
characterized as canonical RNA binding regions. Apart from the predicted Zinc finger
region from 302-324 amino acid (Figure 13 G), which is also present in COE1 transcription
factor, no other region on ECD seems predicted RNA binding site. As discussed earlier
C terminus of ECD contains highly intrinsically disordered region which may be potential
RNA binding region, however, our initial domain analysis shows N-terminus of ECD is
more likely to bind to RNA (Figure 13 D). While highly unlikely, there remains a possibility
that ECD is pulling down an interacting partner or partners that can bind to mRNA, in our
purification process. Further studies are ongoing to clearly define the RNA binding
capability of ECD and its functional implication in physiological and pathological
conditions.
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Figure 12.

A.

Figure 12A. Schematic showing predicted domains in ECD
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Figure. 12. ECD directly binds to RNA. (B) Coomassie stained SDS page gel shows
insect purified DDX39A protein and GST purified ECD protein and ECD Δ A.D and ECD
P617G with or without precision protease to cleave GST. * indicates the purified protein.
(C) RNA EMSA was performed with bacterial purified ECD (5 to 15 µg lanes 3 to 5) and
baculoviral purified DDX39A (5 µg) along with biotinylated probe. DDX39A was used as a
positive control (lane 2 and 6). Competition with 100-fold excess unlabeled probe was
used to show the specificity (lanes 6 & 7). (H.E =higher exposure and L.E =Lower
exposure). (D) RNA EMSA, using anti-FLAG affinity
DDX39A from HEK-293T cells, FLAG-DDX39A

purified FLAG-tagged ECD or

(lanes 2 to 5, with increasing

concentration from 0.2 to 0.8 µg) as positive control and FLAG-ECD (lanes 6 to 9, with
increasing concentration from 0.2 to 0.8 µg) and competition with 100 fold excess
unlabeled probe (lane 10). The samples were run on 7.5 % native gel, transferred
to H-bond membrane, and developed with Streptavidin-HRP based on manufactures’
instructions on light shift chemiluminescent RNA EMSA kit.
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Figure 13.
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Figure. 13. Only ECD ΔAD mutant shows indifferent binding with mRNA. (A) RNA
EMSA was performed with bacterial purified ECD (5 to 15 µg lanes 3 to 5) and ECD Δ A.D
(5 to 15 µg lanes 6 to 8), (baculoviral purified DDX39A (5 µg) along with biotinylated probe.
DDX39A was used as a positive control (lane 2 and 9). Competition with 100-fold excess
unlabeled probe was used to show the specificity (lanes 9 &10). (B) Similarly RNA EMSA
was performed with bacterial purified ECD (5 to 15 µg lanes 3 to 5) and ECD P617G (5 to
15 µg lanes 6 to 8), (baculoviral purified DDX39A (5 µg) along with biotinylated probe.
DDX39A was used as a positive control (lane 2 and 9). Competition with 100-fold excess
unlabeled probe was used to show the specificity (lanes 9 &10). (C) Coomassie stained
SDS page of His purified ECD 1-432, 1-567 and ECD ΔA.D, indicating purity of the
proteins. D) RNA EMSA was performed with these protein 1-432 (lane 4), 1-567 (lane 5)
and ECD ΔA.D was in (lane 6 to 8) and baculoviral purified DDX39A (5 µg) along with
biotinylated probe were added in lane 2 and 9. DDX39A was used as a positive control
(lane 2 and 9). Competition with 100-fold excess unlabeled probe was used to show the
specificity (lanes 9 &10). E) Coomassie stained SDS page of GST purified ECD F.L, ECD
Δ554-562 and ECD Δ302-324 with and without precision protease to cleave GST. *
indicates the purified protein. . (F&G) RNA EMSA was performed with bacterial purified
ECD (5 to 15 µg lanes 3 to 5) and ECD Δ 554 to 562 (F) or and ECD Δ 302-324 (G) (5 to
15 µg lanes 6 to 8), (baculoviral purified DDX39A (5 µg) along with biotinylated probe.
DDX39A was used as a positive control (lane 2 and 9). Competition with 100-fold excess
unlabeled probe was used to show the specificity (lanes 9 &10)
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Chapter 4

Overall conclusions and Future Directions
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In this thesis, we addressed the role of ECD in mRNA processing through our analysis of
data obtained from affinity purification and mass spectrometry. We first confirmed our
Mass spec data using immunoprecipitation and GST pull down assays (Figure 3). My
thesis focus is on mRNA export and ECD-binding proteins, such as DDX39A, DDX39B
and LRPPRC that are involved in mRNA export(24,102). After confirming the interactions
by two methods, next we established FISH assays in two different cell system normal
mammalian epithelial cells (Figure 4A-G) and our mouse embryonic fibroblasts from
ECDfl/fl cells(Figure 4H-J) ) to demonstrate that ECD depletion or deletion led to mRNA
nuclear export block using an abundantly expressed Poly A mRNA. Next, we showed
ECD’s interaction with DDX39A is necessary for ECD-mediated mRNA export, by using a
point mutant of ECD P617G mutant that is defective in binding to DDX39A. We showed
that wild-type ECD but not P617G mutant was able to rescue the ECD depletion mediated
mRNA export(Figure 6)
We have also established the role of ECD in ErbB2 nuclear export. Given our previous
finding that ECD is overexpressed in ErbB2+ breast cancer cells and its overexpression
predicts poor prognosis and short survival in these patients, these experiments were
significant in linking ECD to ErbB2 (42). Using two ErbB2 overexpressing cell lines SKBR3
and BT474, we showed ECD plays a role in maintenance of ErbB2 mRNA as well as
protein expression. ECD downregulation in these cells resulted in downregulation of both
mRNA as well as protein levels of ErbB2 (Figure 7 A&B). In addition, this downregulation
was specific for ErbB2, when we compared with another breast cancer cell line which is
driven by high EGFR,. ECD depletion did not affect the levels of EGFR mRNA or protein
(Figure 7B).
Use of a specific probe against ErbB2 tagged with CY5 in a RNA FISH assay showed
ECD regulates nuclear export of ErbB2 . (Figure 8). We further confirmed these results
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biochemically after subcellular RNA fractionation, where we isolated mRNA from total,
cytoplasmic and nuclear fraction in control, DDX39A and ECD siRNA treated cells. The
nuclear cytoplasmic ratio of ErbB2 mRNA was high in both ECD and DDX39A
downregulated cells as well as the total levels of ErbB2 were going down (Figure 8 A-F).
These cells are highly dependent on ErbB2 for the oncogenic property like invasion and
migration; and consequently ECD depletion resulted in decrease in oncogenic traits
(Figure 9 &10) providing a potential link of why overexpression of ECD provides poor
prognosis and short survival in ErbB2+ patients. (11).
Next, we moved on to address how ECD in involved in mRNA processing (third chapter).
Given ECD depletion does not cause any change in the levels or localization of ECDassociated proteins like DDX39A and LRPPRC (Figure 5), we asked if ECD itself is a RNA
binding protein. EMSA assays with GST-fusion precision cleaved purified proteins or Flagtagged purified proteins were used to explore the association of ECD and RNA. We utilized
a biotinylated mRNA probe that was shown to bind to DDX39A, as well as we used
DDX39A as our control in these assays and demonstrated that similar to DDX39A, ECD
binds to RNA (80). (Figure 12 B-D). Our mutational analyses showed deletion of acidic
amino acid in ECD was more efficient for mRNA binding (Figure 13). Further studies are
required to define the RNA binding domain on ECD as well as implication of RNA binding
to its function in mRNA processing as well as cell cycle block and ER stress regulation.
In conclusion, we have demonstrated ECD regulates nuclear export of mRNA through its
interaction with a nuclear export protein DDX39A. We further demonstrate that ECD
regulates ErbB2 mRNA levels by affecting its premRNA to mRNA levels as well as nuclear
export probably through its interaction with PRPF8 and DDX39A respectively. These
conclusions have been summarized in Figure 14.
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Figure14

Presence of ECD

Absence of ECD

Figure 14. Illustration of plausible mRNA export inside cells in presence and
absence of ECD
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